A. Lim et al. / Tetrahedron Letters 49 (2008) 4882–4885
4885
thanks Yonsei University and Professor K.W.J. at USC for the sup-
ports during the sabbatical year.
5d
1. TBSOTf, CH2Cl2
2,6-lutidine
K2CO3
toluene
2. NaH
DMF
Supplementary data
CH2Br
The 1H NMR copies of 1,3-oxazolidin-2-ones 14 (see Ref. 12)
showing diastereomeric ratios are available. Supplementary data
associated with this article can be found, in the online version, at
TBSO
O
N
O
Cbz
Cbz
N
N
Cbz NH
9 (85%)
10 (83%)
References and notes
Scheme 3. Synthesis of RCM substrates 9 and 10.
1. (a) Gaunt, M. J.; Johansson, C. C. C.; McNally, A.; Vo, N. T. Drug Discovery Today
2007, 12, 8–27; (b) Akiyama, T.; Itoh, J.; Fuchibe, K. Adv. Synth. Catal. 2006, 348,
999–1010; (c) Seayad, J.; List, B. Org. Biomol. Chem. 2005, 3, 719–724; (d) List, B.
Chem. Commun. 2005, 719–722; (e) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed.
2004, 43, 5138–5175; (f) List, B. Acc. Chem. Res. 2004, 37, 548–557; (g) List, B.
Tetrahedron 2002, 58, 5573–5590; (h) Dalko, P. I.; Moisan, L. Angew. Chem., Int.
Ed. 2001, 41, 3726–3748.
2. (a) Bøgevig, A.; Juhl, K.; Kumaragurubaran, N.; Zhuang, W.; Jørgensen, K. A.
Angew. Chem., Int. Ed. 2002, 41, 1790–1793; (b) List, B. J. Am. Chem. Soc. 2002,
124, 5656–5657.
3. Chowdari, N. S.; Ramachary, D. B.; Barbas, C. F., III Org. Lett. 2003, 5, 1685–1688.
4. Umbreen, S.; Brockhaus, M.; Ehrenberg, H.; Schmidt, B. Eur. J. Org. Chem. 2006,
4585–4595.
5. Kotkar, S. P.; Chavan, V. B.; Sudalai, A. Org. Lett. 2007, 9, 1001–1004.
6. Källström, S.; Erkkilä, A.; Pihko, P. M.; Sjöholm, R.; Sillanpää, R.; Leino, R. Synlett
2005, 751–756.
1.2 mmol) followed by allyl bromide (0.10 mL, 1.2 mmol) at 0 °C.
The solution was stirred for 30 min at 0 °C and warmed to room
temperature for 2.5 h. The reaction mixture was quenched with
saturated aqueous NH4Cl (20 mL), extracted with CH2Cl2
(10 mL ꢁ 3). The combined organic solutions were dried over
anhydrous MgSO4 and the residue was chromatographed on silica
gel (hexanes/EtOAc = 6:1) to give 7a (250 mg, 76%) as a colorless
oil; Rf = 0.4 (silica gel, hexanes/EtOAc = 6:1); ½a D20
ꢂ
+7.33 (c 1.00,
CHCl3); 1H NMR (400 MHz, CDCl3) d 7.29–7.23 (m, 10H), 5.89 (m,
1H), 5.26–4.91 (m, 9H), 4.19–3.85 (m, 2H), 2.45–2.03 (m, 2H),
1.25–0.86 (m, 14H), 0.05–0.00 (m, 5H); 13C NMR (62.9 MHz, CDCl3)
d 156.9, 156.4, 135.9, 135.8, 134.4, 133.5, 128.5, 128.2, 128.0,
127.9, 117.4, 72.4, 68.2, 67.9, 67.7, 59.8, 58.7, 56.5, 56.3, 56.0,
7. Zhong, G. Chem. Commun. 2004, 606–607.
8. (a) Henmi, Y.; Kakino, K.; Yoshitomi, Y.; Hara, O.; Hamada, Y. Tetrahedron:
Asymmetry 2004, 15, 3477–3481; (b) Chandrasekhar, S.; Parimala, G.; Tiwari,
B.; Narsihmulu, C.; Sarma, G. D. Synthesis 2007, 1677–1682.
9. Oelke, A. J.; Kumarn, S.; Longbottom, D. A.; Ley, S. V. Synlett 2006, 2548–
2552.
10. (a) Yang, Y.-K.; Tae, J. Synlett 2003, 1043–1045; (b) Yang, Y.-K.; Tae, J. Synlett
2003, 2017–2019; (c) Yang, Y.-K.; Lee, S.; Tae, J. Bull. Korean Chem. Soc. 2004, 25,
1307–1308; (d) Yang, Y.-K.; Choi, J.-H.; Tae, J. J. Org. Chem. 2005, 70, 6995–
6998.
39.2, 38.7, 26.0 18.1, 15.5, 11.6, ꢀ3.8, ꢀ4.1, ꢀ4.3; IR (film, cmꢀ1
)
2954, 2919, 2848, 1714, 1454, 1399, 1301, 1223, 1145, 1086,
1043, 914; HRMS calcd for C31H44N2O5Si (M+): 552.3020; found:
552.3021.
2.3. General procedure for the RCM reaction
11. (a) Tae, J.; Hahn, D.-W. Tetrahedron Lett. 2004, 45, 3757–3760; (b) Kim, Y. J.;
Lee, D. Org. Lett. 2004, 6, 4351–4354.
A
mixture of 7a (135 mg, 0.240 mmol) and 11 (16 mg,
12. The diastereomeric ratios were determined after conversion of
5 to 1,3-
0.024 mmol) in CH2Cl2 (12 mL) was refluxed for 4 h under argon.
After concentration of the solution in vacuo, the residue was chro-
matographed on silica gel (hexanes/EtOAc = 6:1) to give 13a
(115 mg, 92%) as a colorless oil; Rf = 0.3 (hexanes/EtOAc = 6:1);
oxazolidin-2-ones 14 (for the procedures of the cleavage of the N–N bond in
step 3, see: Baumann, T.; Vogt, H.; Bräse, S. Eur. J. Org. Chem. 2007, 266–282).
While the chemical shifts of Ha and Hb for cis-isomers in 14 appear at 3.5–
3.9 ppm and 4.5–4.7 ppm, respectively, those of trans-isomers appear at 3.2–
3.4 ppm and 4.2–4.3 ppm (see Ref. 13 and Supplementary data).
½
a 2D0 +8.71 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) d 7.45–7.32
ꢂ
(m, 10H), 6.05 (m, 2H), 5.30–5.12 (m, 4H), 4.53–4.32 (m, 2H),
3.70–3.80 (m, 1H), 3.22–3.20 (m, 1H), 2.33 (m, 2H) 1.75–1.15 (m,
3H), 0.96–0.91 (m, 9H), 0.18–0.06 (m, 6H); 13C NMR (62.9 MHz,
CDCl3) d 155.1, 154.1, 136.2, 136.0, 128.7, 128.6, 128.5, 128.2,
128.1, 128.0, 127.9, 127.7, 127.5, 126.4 68,1 67.2, 65.7, 43.8, 33.2,
25.8, 18.0, 15.0, ꢀ4.3, ꢀ4.4, ꢀ4.7, ꢀ4.8; IR (film, cmꢀ1) 2954,
2923, 2856, 1711, 1462, 1399, 1356, 1305, 1286, 1258 1231,
cis
trans
R
n
-Pr
1. K2CO3
2. H2, Pd/C
Ha
Hb
Ha
Hb
Ha
Hb
-
R
5
HN
O
Me 3.90 4.57
-
3. NaNO2
HCl-AcOH
i
-Pr 3.54 4.57 3.18 4.27
O
14
n
-Bu 3.72 4.59 3.42 4.18
13. (a) Kano, S.; Yokomatsu, T.; Iwasawa, H.; Shibuya, S. Chem. Lett. 1987, 1531–
1534; (b) Hu, N. X.; Aso, Y.; Otsubo, T.; Ogura, F. J. Org. Chem. 1989, 54, 4398–
4404; (c) Bach, T.; Schlummer, B.; Harms, K. Chem. Eur. J. 2001, 7, 2581–2594.
14. Paquette, L. A.; Mitzel, T. M.; Isaac, M. B.; Crasto, C. F.; Schomer, W. W. J. Org.
Chem. 1997, 62, 4293–4301.
1106, 1086, 1027, 933; HRMS calcd for
547.2707; found: 547.2707.
C
29H40N2O5Si (M+):
Acknowledgments
This work was supported by the Center for Bioactive Molecular
Hybrids (MOST/KOSEF). A.L. thanks BK 21 program (KRF). J.T.